Projects per year
Fingerprint
Dive into the research topics where Reynold Panettieri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
NJ ACTS: A Platform for Translational Science in New Jersey
Panettieri, R. (PI)
National Center for Advancing Translational Sciences
5/1/24 → 4/30/25
Project: Research project
-
Administrative Core
Panettieri, R. (PI)
Agency for Healthcare Research and Quality
1/1/24 → 12/31/24
Project: Research project
-
Learning Health System Scientist Training And Research in New Jersey (LHS STAR NJ)
Hudson, S. (PI), Halm, E. A. (CoPI), Jimenez, M. (CoPI), Panettieri, R. (CoPI) & Gerhard, T. (CoPI)
Agency for Healthcare Research and Quality
1/1/24 → 12/31/24
Project: Research project
-
Core B - Human Cell/Tissue Acquisition and Physiology Care
Panettieri, R. (PI)
National Heart, Lung, and Blood Institute
8/1/23 → 7/31/24
Project: Research project
-
Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study
Papi, A., Chipps, B. E., Beasley, R., Panettieri, R. A., Israel, E., Cooper, M., Dunsire, L., Jeynes-Ellis, A., Rees, R., Albers, F. C. & Cappelletti, C., Jan 1 2024, In: Therapeutic Advances in Respiratory Disease. 18Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Editorial for special issue—human precision cut lung slices: an Ex vivo platform for therapeutic target discovery and drug testing in lung disease
Koziol-White, C. J. & Panettieri, R. A., Dec 2024, In: Respiratory Research. 25, 1, 137.Research output: Contribution to journal › Letter › peer-review
Open Access -
New Jersey Healthcare Essential Worker Outreach and Education Study - Testing Overlooked Occupations (NJ HEROES TOO) project
Hudson, S. & Panettieri, R., Feb 8 2024Research output: Other contribution
-
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review
Papapetropoulos, A., Topouzis, S., Alexander, S. P. H., Cortese-Krott, M., Kendall, D. A., Martemyanov, K. A., Mauro, C., Nagercoil, N., Panettieri, R. A., Patel, H. H., Schulz, R., Stefanska, B., Stephens, G. J., Teixeira, M. M., Vergnolle, N., Wang, X. & Ferdinandy, P., Jun 2024, In: British Journal of Pharmacology. 181, 11, p. 1553-1575 23 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Outcomes of Patients with COPD Treated with ICS/LABA Before and After Initiation of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)
McCormack, M., Paczkowski, R., Gronroos, N. N., Noorduyn, S. G., Lee, L., Veeranki, P., Johnson, M. G., Igboekwe, E., Kahle-Wrobleski, K. & Panettieri, R., Mar 2024, In: Advances in Therapy. 41, 3, p. 1245-1261 17 p.Research output: Contribution to journal › Article › peer-review
Open Access